These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 4414564)
1. Management of melanoma at Hartford Hospital, 1931-1965. Wawro NW; Humphrey C; Adelson L Conn Med; 1974 Aug; 38(8):393-6. PubMed ID: 4414564 [No Abstract] [Full Text] [Related]
2. The result of management of seventy consecutive cases of malignant melanoma from 1939 to 1972 in the Charleston General Hospital, Charleston, West Virginia. Lee HS W V Med J; 1974 May; 70(5):109-18. PubMed ID: 4527021 [No Abstract] [Full Text] [Related]
3. The treatment of advanced malignant melanoma. Retsas S Practitioner; 1980 Oct; 224(1348):1019-21. PubMed ID: 7220428 [No Abstract] [Full Text] [Related]
4. [Melanoma: stages of tumor curability]. Koszarowski T; Romejko M Pol Tyg Lek; 1983 May 30-Jun 6; 38(22-23):673-5. PubMed ID: 6647134 [No Abstract] [Full Text] [Related]
5. [Analysis of survival and annual mortality in malignant skin melanoma on the population level]. Merabishvili VM; Chepik OF Vopr Onkol; 2006; 52(4):385-91. PubMed ID: 17024808 [No Abstract] [Full Text] [Related]
6. Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells. Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S J Dermatol; 2008 Dec; 35(12):801-3. PubMed ID: 19239565 [No Abstract] [Full Text] [Related]
7. [Melanoma from the dermatological viewpoint]. Braun W Dtsch Gesundheitsw; 1970 Jan; 25(4):155-8. PubMed ID: 5447191 [No Abstract] [Full Text] [Related]
8. Ten-year review of overall survival rates for stage I cutaneous melanoma in 3,009 residents of Connecticut. Kern KA Conn Med; 1992 Jun; 56(6):283-5. PubMed ID: 1638858 [No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)]. Denisov LE; Kurdina MI Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912 [TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of malignant melanoma. Krementz ET; Creach O Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120 [No Abstract] [Full Text] [Related]
12. Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients. Gimotty PA; Guerry D; Flaherty K J Clin Oncol; 2008 Feb; 26(4):517-8. PubMed ID: 18235111 [No Abstract] [Full Text] [Related]
13. [Prognostic factors and improving treatment of cutaneous melanoma]. Vihinen P; Kähäri VM; Pyrhönen S Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705 [No Abstract] [Full Text] [Related]
14. Cutaneous melanoma: detecting it earlier, weighing management options. Lane JE; Dalton RR; Sangueza OP J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894 [No Abstract] [Full Text] [Related]
16. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma]. Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461 [No Abstract] [Full Text] [Related]
17. [Comment on the contribution by U. Beiteke et al. Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Second comment]. Gefeller O; Kleeberg U; Kölmel KF Hautarzt; 1994 Mar; 45(3):191-2; author reply 193-4. PubMed ID: 8175352 [No Abstract] [Full Text] [Related]
20. Adjuvant treatment of melanoma using placebo or no therapies as control-arm: is it ethically correct? Ascierto PA; Daponte A; Giuseppe P Melanoma Res; 1999 Oct; 9(5):528-9. PubMed ID: 10596921 [No Abstract] [Full Text] [Related] [Next] [New Search]